Replies to post #343681 on Innovation Pharmaceuticals Inc (IPIX)

[136]

You hit the nail on the head.

I encourage everyone to read your post, and read it again.

$IPIX

IPIX

[Blue Fin]

LilKahuna, Appreciate your reponse to my post this post is more in the realm of my understanding but I did get the drift of the other post after spending awhile trying to absorb some of what I was readng, Thank you.

[To infinity and beyond!]

does "probability" of success mean "very likely". success, as was asserted? The share price of 33 cents should explain how many people actually believe that nonsense.

A healthy skepticism says the lab data may not translate.

currently 33 cents for a very likely COVID treatment success? Ha.

[TheDane]

Excellent points! ...
LilKahuna Wednesday, 02/03/21 09:52:13 PM
Re: To infinity and beyond! post# 343679 0.005
Post # of 343712
“The proposition that one can’t extract from all previous Brilacidin preclinical and clinical data a probability for success is itself patently false. Such a proposition is not simply healthy cynicism, it goes beyond that strongly into willful ignorance of data meaning and implications for successful trial outcomes.

Previous trial outcomes indicate a far stronger safety and efficacy profile than Remdesivir. Had it not been for “better than nothing” efficacy outcomes with its marginal safety, Remdesivir never would have been approved outside a world health emergency environment. The FDA had already failed to approve the drug previously following phase 3 studies.

Brilacidin is safer and shows efficacy profiles stronger than Remdesivir’s. One can easily assess a good likelihood for emergency approval. After all, it only has to be demonstratively better than both nothing and Remdesivir. Is it a slam dunk? No. But it’s much better odds than average. “